Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors

NCT01736917 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy-Induced Nausea and Vomiting

Interventions

DRUG: Fosaprepitant
DRUG: Dexamethasone
DRUG: 5HT3

Sponsor

Lawrence Einhorn

Collaborators

[object Object]
[object Object]